Follow the REGENERON PHARMACEUTICALS INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €78.5bn. The latest transaction was filed on 14 January 2016 (Acquisition). Among the most active insiders: Sanofi. All data is free.
20
Insider Decl.
n/a
Thresholds
n/a
18 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate REGENERON PHARMACEUTICALS INC Buy (bullish), based on 27 analysts. Average price target: US$833.54.
Fundamental score
Ranked 3,672 of 29,064 companies
71.6
score / 100
Value
58
Quality
85
FCF yld4.8%
Earn yld5.7%
EV/EBITDA14.0x
ROE14%
Gross mgn85%
Net mgn31%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
REGENERON PHARMACEUTICALS INC es una empresa biofarmacéutica estadounidense centrada en la investigación, el desarrollo y la comercialización de medicamentos para enfermedades graves. Cotiza en el NASDAQ bajo el símbolo REGN.